HUSH supports application for feasibility study of the drug Eculizumab5th October 2014
HUSH has supported an application for a feasibility study of the drug Eculizumab, for HUS sufferers.
The drug is currently being successfully used for sufferers of a similar illness called aHUS.
This application is supported by medical and public health experts who believe that this drug could be helpful for sufferers of HUS.
The funding application for this study to the National Institute of Health Research is at a very early stage of the process.
The application is lead by Dr Sally Johnson a Consultant Paediatric Nephrologist at Great North Children's Hospital Newcastle and is supported by Paediatric Nephrologists in England, Wales & Scotland.
If the feasibility application & study is successful it is hoped that a trial of the drug will be carried out on HUS sufferers.
1 of 46
A recent news article in the Environmental Health News indicates the concerns the Chartered Institute of Environmental Health (CIEH) have over UK food safety being at risk, due to lack of staff. Food safety allocated posts supporte... ...read on
On the 29th December 2023 the FSA stated on their website “Chiltern Artisan recalls Chilli Sticks because of contamination with E. Coli. Chiltern Artisan has taken the precautionary step of recalling Chiltern Artisan Chilli Sticks because E. Coli has been fo... ...read on
Amy Douglas, Incident Director for Gastrointestinal Infections and Food Safety Division at UKHSA, said: "There have been at least 30 confirmed cases of this specific outbreak strain of STEC in the UK." - Link below. ... ...read on
The recall for Route des Terroirs is recalling Morbier Maison Monts & Terroirs Chalet De Vevy Raw Cows’ Milk Cheese because Shiga toxin-producing E.coli has been found in some batches of this product. This recall was announced today 25/12/2023. ... ...read on
Information Rights Team ... ...read on
1 of 46